eIF4A1 is a promising new therapeutic target in ER-negative breast cancer

CELL DEATH AND DIFFERENTIATION

NATURE PUBLISHING GROUP

1. MRC [MC_UP_A600_1023] Funding Source: UKRI
2. Medical Research Council [MC_UP_A600_1023] Funding Source: researchfish
3. Medical Research Council [MC_UP_A600_1023] Funding Source: Medline